📰 Reset Pharmaceuticals News
Reset Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Reset Pharmaceuticals. Real-time updates on events, politics, business and more.
November 1, 2023
Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health conditions related to life-altering diseases, today announces that the Company has received a Safe to Proceed notification from the U.S. Food and Drug Administration (FDA) regarding its Invest
September 1, 2023
Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce a significant licensing agreement between Filament Health and Reset...
August 31, 2023
This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in patients with majo
April 25, 2023
Fried food consumption was associated with higher risks for anxiety and depression, according to findings published in the Proceedings of the National Academy of Sciences of the United States of America.
January 5, 2023
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer 05.01.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceuticals Appoints Innes Meldrum as...
November 2, 2022
EQS-News: Reset Pharmaceuticals, Inc. / Key word(s): Personnel Reset Pharmaceuticals announces appointment of neuroscience industry leader Lisa Deschamps to the Board of Directors 02.11.2022 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Reset Pharmaceut...
July 8, 2021
Published: Jul 07, 2021 By Alex Keown Collaborations are part of the life’s blood of clinical development as biopharma and life sciences companies partner and pool resources to develop novel therapies and treatments for a myriad of diseases. This morning, multiple companies announced clinical and strategic collaborations. PureTech Health to Harness BeiGene’s Checkpoint Inhibitor Boston-based PureTech Health plc and forged an alliance to assess the combination of BeiGene’s ex...